Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
110 studies found for:    "Hepatic encephalopathy"
Show Display Options
Rank Status Study
1 Completed Rifaximin in Minimal Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: placebo
2 Terminated The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
3 Completed Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Condition: Hepatic Encephalopathy
Interventions: Drug: VSL#3;   Other: Placebo
4 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
5 Recruiting The Effects of Nitazoxanide in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Nitazoxanide;   Drug: Oral lactulose;   Drug: Metronidazole;   Drug: Rifaximine
6 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
7 Terminated
Has Results
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
8 Completed Cerebrovascular Reactivity in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention:
9 Unknown  Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate and lactulose;   Drug: placebo and lactulose
10 Completed A Retrospective Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) (The RETRO Study)
Condition: Hepatic Encephalopathy
Intervention:
11 Completed Study of Rifaximin in Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: rifaximin
12 Completed Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: L-Ornithine L-Aspartate
13 Unknown  RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
14 Completed Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: Albumin
15 Completed Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: L-ornithine L-aspartate;   Drug: Rifaximin;   Drug: Placebo
16 Unknown  The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
17 Completed Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Biological: Lactobacillus GG;   Biological: Placebo
18 Unknown  ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study
Condition: Hepatic Encephalopathy
Intervention: Dietary Supplement: probiotic VSL#3
19 Completed Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate;   Drug: Lactose
20 Completed Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: AST-120;   Drug: lactulose

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.